Cited by 100Dementia and Cognitive Impairment ResearchNeural and Behavioral Psychology StudiesHistorical and Modern Theater Studies

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Improving response inhibition systems in frontotemporal dementia with citalopram

Open access

Abstract

Disinhibition is a cardinal feature of the behavioural variant of frontotemporal dementia, presenting as impulsive and impetuous behaviours that are often difficult to manage. The options for symptomatic treatments are limited, but a potential target for therapy is the restoration of serotonergic function, which is both deficient in behavioural variant frontotemporal dementia and closely associated with inhibitory control. Based on preclinical studies and psychopharmacological interventions in other disorders, we predicted that inhibition would be associated with the right inferior frontal gyrus and dependent on serotonin. Using magnetoencephalography and electroencephalography of a Go-NoGo paradigm, we investigated the neural basis of behavioural disinhibition in behavioural variant frontotemporal dementia and the effect of selective serotonin reuptake inhibition on the neural systems for response inhibition. In a randomized double-blinded placebo-controlled crossover design study, 12 patients received either a single 30 mg dose of citalopram or placebo. Twenty age-matched healthy controls underwent the same magnetoencephalography/electroencephalography protocol on one session without citalopram, providing normative data for this task. In the control group, successful NoGo trials evoked two established indices of successful response inhibition: the NoGo-N2 and NoGo-P3. Both of these components were significantly attenuated by behavioural variant frontotemporal dementia. Cortical sources associated with successful inhibition in control subjects were identified in the right inferior frontal gyrus and anterior temporal lobe, which have been strongly associated with behavioural inhibition in imaging and lesion studies. These sources were impaired by behavioural variant frontotemporal dementia. Critically, citalopram enhanced the NoGo-P3 signal in patients, relative to placebo treatment, and increased the evoked response in the right inferior frontal gyrus. Voxel-based morphometry confirmed significant atrophy of inferior frontal gyrus, alongside insular, orbitofrontal and temporal cortex in our patient cohort. Together, these data suggest that the dysfunctional prefrontal cortical systems underlying response inhibition deficits in behavioural variant frontotemporal dementia can be partially restored by increasing serotonergic neurotransmission. The results support a translational neuroscience approach to impulsive neurological disorders and indicate the potential for symptomatic treatment of behavioural variant frontotemporal dementia including serotonergic strategies to improve disinhibition.media-1vid110.1093/brain/awv133_video_abstractawv133_video_abstract.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awv133

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Laura et al. found that citalopram can partially restore the dysfunctional prefrontal cortical systems by increasing serotonergic neurotransmission in FTD.

    “In line with our observation, Laura et al. [56] found that citalopram can partially restore the dysfunctional prefrontal cortical systems by increasing serotonergic neurotransmission in FTD.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 94

  1. 10.1016/j.neuroimage.2013.03.011 · DOI
  2. Almeida, 2010, Acute citalopram administration may disrupt contextual information processing in healthy males, Eur Psychiatry, 25, 87, 10.1016/j.eurpsy.2009.05.010 · DOI
  3. 10.1097/00001756-200208270-00012 · DOI · Paper page
  4. 10.1016/j.tics.2004.02.010 · DOI · Paper page
  5. 10.1016/j.tics.2013.12.003 · DOI · Paper page
  6. 10.1016/j.neuroimage.2007.07.007 · DOI · Paper page
  7. 10.1016/S0001-6918(99)00005-0 · DOI · Paper page
  8. Bentivoglio, 2012, Neuropsychological features of patients with Parkinson's disease and impulse control disorders, Neurol Sci, 34, 1207, 10.1007/s10072-012-1224-5 · DOI
  9. 10.1016/0013-4694(94)90094-9 · DOI · Paper page
  10. 10.1016/j.neuropsychologia.2011.05.014 · DOI
  11. 10.1016/j.neuropsychologia.2007.12.008 · DOI
  12. 10.1016/j.neuropsychologia.2004.08.010 · DOI
  13. 10.1016/j.bbr.2012.08.003 · DOI
  14. 10.1007/s00213-007-0992-8 · DOI
  15. 10.1097/WAD.0b013e31815c345e · DOI
  16. 10.1016/j.biopsych.2004.02.029 · DOI · Paper page
  17. 10.1007/s00213-001-0986-x · DOI
  18. 10.1016/S0010-9452(08)70686-5 · DOI
  19. 10.1016/j.biopsych.2011.03.028 · DOI · Paper page
  20. 10.1038/npp.2010.121 · DOI · Paper page
  21. 10.1016/j.tics.2007.10.011 · DOI · Paper page
  22. 10.1016/j.jneumeth.2008.12.010 · DOI
  23. 10.1007/s00213-003-1686-5 · DOI
  24. 10.1016/j.bandc.2004.04.005 · DOI · Paper page
  25. 10.1212/WNL.55.11.1621 · DOI · Paper page
  26. 10.1007/s00213-008-1127-6 · DOI · Paper page
  27. 10.1038/npp.2008.202 · DOI
  28. 10.1007/s00213-006-0411-6 · DOI · Paper page
  29. 10.1016/j.clinph.2006.05.002 · DOI
  30. 10.1027//0269-8803.16.3.167 · DOI · Paper page
  31. 10.1016/j.cortex.2012.09.008 · DOI
  32. 10.1002/ana.20365 · DOI
  33. 10.1017/S0317167100005680 · DOI
  34. 10.1111/j.1469-8986.1991.tb00417.x · DOI
  35. 10.1098/rstb.2012.0407 · DOI
  36. 10.1016/S0166-4328(98)00117-X · DOI
  37. 10.1097/JGP.0b013e31823033f3 · DOI
  38. 10.1093/brain/awr196 · DOI
  39. 10.1162/jocn_a_00356 · DOI
  40. 10.1016/j.ijpsycho.2012.08.001 · DOI
  41. 10.1016/j.neuroimage.2014.02.034 · DOI
  42. 10.1159/000076343 · DOI
  43. Ishikawa, 2006, Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia, Seishin Shinkeigaku Zasshi, 108, 1029
  44. 10.1002/mds.26049 · DOI
  45. 10.1016/j.euroneuro.2013.01.003 · DOI
  46. 10.1093/brain/awp077 · DOI
  47. 10.1097/WCO.0b013e3283404309 · DOI
  48. 10.1093/brain/122.5.981 · DOI · Paper page
  49. 10.1046/j.1460-9568.1998.00167.x · DOI · Paper page
  50. 10.1186/1471-2377-13-179 · DOI
  51. 10.1016/j.pscychresns.2007.07.003 · DOI
  52. 10.1159/000077171 · DOI
  53. 10.1038/npp.2012.264 · DOI
  54. 10.1016/j.neuroimage.2003.09.032 · DOI
  55. 10.1016/S1053-8119(03)00169-1 · DOI
  56. 10.1002/mds.20465 · DOI
  57. 10.1159/000067021 · DOI
  58. 10.1371/journal.pone.0085747 · DOI
  59. 10.1196/annals.1377.004 · DOI
  60. 10.1097/WAD.0b013e318265bbc9 · DOI
  61. 10.1016/j.cortex.2012.12.003 · DOI
  62. Pascual-Marqui, 2002, Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details, Methods Find Exp Clin Pharmacol, 24, 5
  63. 10.1212/WNL.0b013e3181a55fa2 · DOI
  64. 10.1016/j.nbd.2010.05.028 · DOI
  65. 10.1126/scitranslmed.3003391 · DOI
  66. 10.1016/j.neurobiolaging.2014.07.008 · DOI
  67. 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J · DOI
  68. 10.1159/000051219 · DOI
  69. 10.1016/j.clinph.2011.05.012 · DOI
  70. 10.1093/brain/awr179 · DOI · Paper page
  71. 10.1098/rstb.2007.2097 · DOI · Paper page
  72. 10.1007/s00221-004-1985-z · DOI
  73. 10.1212/WNL.0b013e318202038c · DOI · Paper page
  74. 10.1093/brain/awn112 · DOI
  75. 10.1006/nimg.2000.0685 · DOI · Paper page
  76. 10.1007/s00702-008-0042-7 · DOI
  77. Sangkuhl, 2011, PharmGKB summary: citalopram pharmacokinetics pathway, Pharmacogenet Genomics, 769, 10.1097/FPC.0b013e328346063f · DOI
  78. 10.1001/archneur.61.7.1104 · DOI
  79. 10.1016/j.ijpsycho.2012.07.185 · DOI
  80. 10.1016/j.clinph.2007.11.042 · DOI
  81. 10.1016/j.ijpsycho.2009.11.002 · DOI
  82. 10.1001/archneur.1991.00530200032014 · DOI
  83. 10.4088/JCP.v58n0506 · DOI
  84. 10.1016/j.neuroimage.2011.02.070 · DOI · Paper page
  85. 10.1006/nimg.2001.0978 · DOI · Paper page
  86. Vara, 2014, Is inhibitory control a ‘no-go' in adolescents with autism spectrum disorder?, Molecular Autism, 31, 6, 10.1186/2040-2392-5-6 · DOI
  87. 10.1111/j.1460-9568.2005.04571.x · DOI · Paper page
  88. 10.1136/jnnp.2007.122028 · DOI
  89. 10.1001/archneurol.2010.65 · DOI
  90. 10.1212/01.wnl.0000343851.46573.67 · DOI
  91. 10.1016/j.neuroimage.2004.10.023 · DOI
  92. Yang, 2001, Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method, Acta Neuropathol, 101, 256, 10.1007/s004010000293 · DOI
  93. Ye, 2014, Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease, Brain, 197, 145
  94. 10.1162/jocn.2008.20100 · DOI

Cited by

Sorted by citations

Metadata

Authors
Hughes, L. E., Rittman, T., Regenthal, R., Robbins, T. W., & Rowe, J. B.
Affiliations
  • MRC Cognition and Brain Sciences Unit (GB)
  • University of Cambridge (GB)
  • Leipzig University (DE)
Corresponding author
Hughes, Laura E.
Venue
Brain
Published
2015-05-21
Volume
138
Issue
7
Pages
1961-1975
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W1908432422
Cited by
100
References
14
Citations by year
2026: 14 · 2025: 9 · 2024: 7 · 2023: 5 · 2022: 11 · 2021: 17 · 2020: 9 · 2019: 5 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 1
FWCI
5.19
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Brain (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (103838/Z/14/Z, 103838, 088324, 093875)
  • Medical Research Council (MR/M024873/1, MR/M009041/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
Keywords
behavioral variant frontotemporal dementia, citalopram, response inhibition, disinhibition, serotonergic function, selective serotonin reuptake inhibitors, go/no-go task, Nogo-P3, Nogo-N2, right inferior frontal gyrus, anterior temporal lobe, prefrontal cortex, cortical atrophy, impulsivity, symptomatic treatment
MeSH terms
Aged, Double-Blind Method, Electroencephalography, Female, Humans, Inhibition, Psychological, Magnetic Resonance Imaging, Male, Middle Aged, Magnetoencephalography, Citalopram, Selective Serotonin Reuptake Inhibitors, Cross-Over Studies, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review